Physician Wealth Advisors’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
Other funds holding LRMR
Physician Wealth Advisors's LRMR Position: Q3 2026 in Review
Physician Wealth Advisors held its Larimar Therapeutics (LRMR) position steady in Q3 2026 at 233 shares worth $745. The position accounts for ﹤0.01% of the portfolio, ranked #2063.
Physician Wealth Advisors first reported a position in LRMR in Q2 2025 and has held it in 6 quarters since. The position peaked at $1.05K in Q1 2026. 147 funds tracked by Wall St. Rank hold LRMR as of Q3 2026.
- Physician Wealth Advisors held 233 shares of Larimar Therapeutics worth $745 as of Q3 2026.
- Physician Wealth Advisors left its Larimar Therapeutics share count unchanged in Q3 2026.
- Larimar Therapeutics made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q3 2026, its #2063 holding.
- Physician Wealth Advisors first reported a position in Larimar Therapeutics in Q2 2025 and has held it in 6 quarters since.
- Physician Wealth Advisors's Larimar Therapeutics position peaked at $1.05K in Q1 2026.
- 147 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q3 2026.
Based on Physician Wealth Advisors's 13F filing for Q3 2026, filed 20 Oct 2026.